NuScriptRx Revenue and Competitors
Estimated Revenue & Valuation
- NuScriptRx's estimated annual revenue is currently $10.1M per year.
- NuScriptRx's estimated revenue per employee is $201,000
Employee Data
- NuScriptRx has 50 Employees.
- NuScriptRx grew their employee count by -2% last year.
NuScriptRx's People
Name | Title | Email/Phone |
---|---|---|
1 | President and CEO | Reveal Email/Phone |
NuScriptRx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.2M | 6 | 20% | N/A | N/A |
#2 | $152.8M | 543 | 0% | $28.5M | N/A |
#3 | $102.7M | 511 | 0% | N/A | N/A |
#4 | $62.1M | 309 | 6% | N/A | N/A |
#5 | $10.1M | 50 | -2% | N/A | N/A |
#6 | $31.2M | 155 | -4% | N/A | N/A |
#7 | $23.7M | 118 | 12% | $23.6M | N/A |
#8 | $5.8M | 29 | 4% | N/A | N/A |
#9 | $14.3M | 71 | 27% | N/A | N/A |
#10 | $15.9M | 79 | 7% | N/A | N/A |
What Is NuScriptRx?
NuScriptRx Based in Nashville, Tenn., NuScriptRX is an institutional pharmacy that serves the pharmaceutical needs of long-term care facilities and their patients. Institutional long-term care pharmacy with: * A unique reduced cost of medication dispensing model - Highly automated robotic system for dispensing pharmaceuticals on a short cycle basis, providing medications in specialized unit dose patient packaging * Improved medication access - By providing localized remote dispensing through an integrated technology enabled system in each client's long-term care or rehab facility to improve medication access on a 24/7 basis * Higher quality assurance standards for patients - By enabling nurses to provide higher quality assurance / safety through our patient dosing system combined with an integrated medication management system (i.e. doses by medpass time with barcoding)
keywords:N/AN/A
Total Funding
50
Number of Employees
$10.1M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $10.8M | 50 | 4% | N/A |
#2 | $11.6M | 50 | 9% | N/A |
#3 | $9.4M | 50 | 9% | N/A |
#4 | $6M | 50 | 39% | N/A |
#5 | $10.8M | 50 | 4% | N/A |